WallabyPhenox Announces Completion of Strategic Financing and Debt Restructuring to Accelerate Global Expansion
Wallaby Medical
Developer and Producer of Therapeutic Products in the Neurointervention Field
YF Capital
Private equity funds primarily involved in the fields of internet, healthcare, entertainment, finance, logistics, and consumer goods.
Gaorong Ventures
Venture Capital Institution
Qianhai Ark
Investment and Asset Management Institutions
Enlight Medical
Innovative Medical Device Development and Manufacturer
On March 18, global neurovascular medical technology company Wallaby Medical (WallabyPhenox) announced the successful completion of a significant equity financing round and debt restructuring. This round of financing was jointly led by YF Capital, Hillhouse Investment, Gaorong Ventures, Huajie High View, Jiachen Capital, and Qianhai Ark Asset Management, with Enlight Medical participating as a follow-up investor. The proceeds from this round of financing will be used to optimize the capital structure and accelerate the company's long-term global growth strategy.
Wallaby Medical was founded in December 2015, focusing on providing innovative, breakthrough, and clinically validated stroke treatment technologies and solutions. To date, Wallaby Medical has 5 research and development centers, 3 production bases, and over 700 employees worldwide, with more than 200 global patents obtained.